Corrigendum | Open Access
Corrigendum to “Sphingolipids as Mediators in the Crosstalk between Microbiota and Intestinal Cells: Implications for Inflammatory Bowel Disease”
In the article titled “Sphingolipids as Mediators in the Crosstalk between Microbiota and Intestinal Cells: Implications for Inflammatory Bowel Disease” , reference  was incorrectly added as follows:“Y. Chen, S.-C. Xu, and R.-D. Duan, ‘Mevalonate inhibits acid sphingomyelinase activity, increases sphingomyelin levels and inhibits cell proliferation of HepG2 and Caco-2 cells,’ Lipids in Health and Disease, vol. 14, no. 1, article 130, 2015.”It should be replaced with the following reference:“Chen Y, et al. Enhanced colonic tumorigenesis in alkaline sphingomyelinase (NPP7) knockout mice. Mol Cancer Ther, 14:1, 259-67, 2015.”
- P.-F. Bryan, C. Karla, M.-T. Edgar Alejandro, E.-P. Sara Elva, F. Gemma, and C. Luz, “Sphingolipids as mediators in the crosstalk between microbiota and intestinal cells: implications for inflammatory bowel disease,” Mediators of Inflammation, vol. 2016, Article ID 9890141, 11 pages, 2016.
Copyright © 2016 Bryan Phillips-Farfán et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.